Hostname: page-component-f554764f5-sl7kg Total loading time: 0 Render date: 2025-04-13T23:35:36.065Z Has data issue: false hasContentIssue false
  • English
  • Français

Radiofrequency catheter ablation for ventricular tachycardia in ischaemic cardiomyopathy due to Kawasaki disease

Part of: Electrophysiology

Published online by Cambridge University Press:  16 April 2018

Hisaaki Komaki ,
Takashi Nakashima  and
Shinya Minatoguchi
Hisaaki Komaki*
Affiliation:
Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
Takashi Nakashima
Affiliation:
Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
Shinya Minatoguchi
Affiliation:
Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan
*
Author for correspondence: H. Komaki, MD, Department of Cardiology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. Tel: +81 90 9020 8567; Fax: +81 58 230 6524; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

In some patients with Kawasaki disease, a prior myocardial infarction causes ventricular tachycardia in the chronic post-myocardial infarction phase. We report the case of a 41-year-old man with symptomatic and haemodynamically unstable ventricular tachycardia in whom substrate ablation was performed for the ventricular tachycardia before insertion of an implantable cardioverter-defibrillator.

Keywords

Radiofrequency catheter ablationventricular tachycardiamyocardial infarctionmucocutaneous lymph node syndromeKawasaki disease
Type
Brief Report
Information
Cardiology in the Young , Volume 28 , Issue 6 , June 2018 , pp. 890 - 893
Check for updates
Copyright
© Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Tsuda, E, Matsuo, M, Naito, H, Noguchi, T, Nonogi, H, Echigo, S. Clinical features in adults with coronary arterial lesions caused by presumed Kawasaki disease. Cardiol Young 2007; 17: 84–89.CrossRefGoogle ScholarPubMed
2. Orenstein, JM, Shulman, ST, Fox, LM, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One. 2012; 7: e38998.CrossRefGoogle ScholarPubMed
3. Vergara, P, Trevisi, N, Ricco, A, et al. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol 2012; 23: 621–627.CrossRefGoogle ScholarPubMed
4. Di Biase, L, Burkhardt, JD, Lakkireddy, D, et al. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial. J Am Coll Cardiol 2015; 66: 2872–2882.CrossRefGoogle ScholarPubMed
5. Sacher, F, Tedrow, UB, Field, ME, et al. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol 2008; 1: 153–161.CrossRefGoogle ScholarPubMed
6. Stevenson, WG, Wilber, DJ, Natale, A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 2008; 118: 2773–2782.CrossRefGoogle ScholarPubMed
7. Jais, P, Maury, P, Khairy, P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation 2012; 125: 2184–2196.CrossRefGoogle ScholarPubMed
8. Zipes, DP, Camm, AJ, Borggrefe, M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e385–e484.CrossRefGoogle Scholar
9. de Bakker, JM, Wittkampf, FH. The pathophysiologic basis of fractionated and complex electrograms and the impact of recording techniques on their detection and interpretation. Circ Arrhythm Electrophysiol 2010; 3: 204–213.CrossRefGoogle ScholarPubMed
10. Nakahara, S, Tung, R, Ramirez, RJ, et al. Distribution of late potentials within infarct scars assessed by ultra high-density mapping. Heart Rhythm. 2010; 7: 1817–1824.CrossRefGoogle ScholarPubMed
11. Reddy, VY, Reynolds, MR, Neuzil, P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007; 357: 2657–2665.CrossRefGoogle ScholarPubMed
12. Sapp, JL, Wells, GA, Parkash, R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016; 375: 111–121.CrossRefGoogle ScholarPubMed
Supplementary material: Image

Komaki et al. supplementary material

Komaki et al. supplementary material 1

Download Komaki et al. supplementary material(Image)
Image 72.4 KB